Consumers more likely to embrace AI in commerce than healthcare

Only 51% of consumers feel optimistic or safe when it comes to AI infiltrating the healthcare space in the form of helping providers in diagnostic decision making and care management, according to a recent survey from Blumberg Capital.

Another 49% said they feel unsafe and fearful of AI in healthcare, including the technology aiding in selecting which medicine to take or whether to undergo surgery.

In fact, consumers today are much more likely to embrace AI in other sectors, such as commerce and entertainment, in part because these areas may not require as much personal data. More than half of survey respondents said they lack confidence that their private information will stay secure. At the same time, 41% of consumers say that businesses using AI will become more careful about protecting personal data.

“AI is a powerful technology that operates behind the scenes with the potential to change all of our lives and, unbeknownst to many, it already has,” David J. Blumberg, founder and managing partner, Blumberg Capital, said in a statement. “This survey shows that while a percentage of consumers are comfortable with AI, many are concerned about how it is and will be used by companies and governments in the future. 

Still, 33% said they were comfortable and trusting of AI when used for commerce, as well as 30% for cybersecurity and 16% for entertainment and social media. In addition, healthcare is hardly the area that comes to mind when people think of AI. More than half of respondents said they primarily think of robots when they think of AI and 40% said they think about self-driving cars.

In the future, consumers are more likely to accept AI in healthcare, the survey revealed, and they see it as a strong opportunity for the technology.

“In looking ahead, consumers rank healthcare as the industry to be most greatly impacted through adoption of AI over the next 10 years,” the survey reads.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.